Go Pro

Astrazeneca (AZN) News Today

Astrazeneca logo
$159.98 -0.20 (-0.12%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$163.24 +3.26 (+2.04%)
As of 08:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Astrazeneca Latest News

FY2026 EPS Estimates for Astrazeneca Increased by Analyst
Erste Group Bank Expects Stronger Earnings for Astrazeneca
AstraZeneca’s breast cancer pill falls short
AstraZeneca: The $5 Billion Pipeline Hole Did Not Stay Open Long
Jim Cramer Says He Is Not Going to Put His Money on AstraZeneca (AZN)
Astrazeneca's breast cancer drug fails late-stage trial
Positive Lung Cancer Data Lifts the Case for Amgen and AstraZeneca
AstraZeneca's $5bn drug promise is no 'buy' signal for Deutsche
AstraZeneca slips Wednesday, underperforms market
AstraZeneca falls Tuesday, underperforms market
Astrazeneca Plc $AZN Shares Sold by Groupe la Francaise
Amundi Purchases 1,036,635 Shares of Astrazeneca Plc $AZN
AstraZeneca Flat on License Pact
AstraZeneca prices €2.55bn euro bond sale across four tranches

Astrazeneca Media Mentions By Week

Astrazeneca Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AZN
News Sentiment

0.53

0.89

Average
Healthcare
News Sentiment

Astrazeneca News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AZN Articles
This Week

29

8

AZN Articles
Average Week

Astrazeneca Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
6
+500%
Page Views
4,384
-19%
Get Astrazeneca News Delivered to You Automatically

Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Astrazeneca dated 9/14/2026.
From Our Partners